Global Monovalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 93

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

According to our (Global Info Research) latest study, the global Monovalent Antivenom market size was valued at USD 395.1 million in 2022 and is forecast to a readjusted size of USD 484.8 million by 2029 with a CAGR of 3.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

This report is a detailed and comprehensive analysis for global Monovalent Antivenom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Monovalent Antivenom market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Monovalent Antivenom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Monovalent Antivenom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Monovalent Antivenom market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monovalent Antivenom
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monovalent Antivenom market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Monovalent Antivenom market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Coral Snakes Antivenom
    Sea Snakes Antivenom
    Brown Snake Antivenom
    Others

Market segment by Application
    Non-profit Institutions
    Hospitals and Clinic

Major players covered
    CSL
    Merck
    BTG
    Pfizer
    Haffkine Bio-Pharmaceutical
    Vins Bioproducts
    Serum Biotech

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Monovalent Antivenom product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Monovalent Antivenom, with price, sales, revenue and global market share of Monovalent Antivenom from 2018 to 2023.
Chapter 3, the Monovalent Antivenom competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monovalent Antivenom breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Monovalent Antivenom market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Monovalent Antivenom.
Chapter 14 and 15, to describe Monovalent Antivenom sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Monovalent Antivenom
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Monovalent Antivenom Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Coral Snakes Antivenom
        1.3.3 Sea Snakes Antivenom
        1.3.4 Brown Snake Antivenom
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Monovalent Antivenom Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Non-profit Institutions
        1.4.3 Hospitals and Clinic
    1.5 Global Monovalent Antivenom Market Size & Forecast
        1.5.1 Global Monovalent Antivenom Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Monovalent Antivenom Sales Quantity (2018-2029)
        1.5.3 Global Monovalent Antivenom Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Monovalent Antivenom Product and Services
        2.1.4 CSL Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 CSL Recent Developments/Updates
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Monovalent Antivenom Product and Services
        2.2.4 Merck Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck Recent Developments/Updates
    2.3 BTG
        2.3.1 BTG Details
        2.3.2 BTG Major Business
        2.3.3 BTG Monovalent Antivenom Product and Services
        2.3.4 BTG Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 BTG Recent Developments/Updates
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Monovalent Antivenom Product and Services
        2.4.4 Pfizer Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Pfizer Recent Developments/Updates
    2.5 Haffkine Bio-Pharmaceutical
        2.5.1 Haffkine Bio-Pharmaceutical Details
        2.5.2 Haffkine Bio-Pharmaceutical Major Business
        2.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
        2.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
    2.6 Vins Bioproducts
        2.6.1 Vins Bioproducts Details
        2.6.2 Vins Bioproducts Major Business
        2.6.3 Vins Bioproducts Monovalent Antivenom Product and Services
        2.6.4 Vins Bioproducts Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Vins Bioproducts Recent Developments/Updates
    2.7 Serum Biotech
        2.7.1 Serum Biotech Details
        2.7.2 Serum Biotech Major Business
        2.7.3 Serum Biotech Monovalent Antivenom Product and Services
        2.7.4 Serum Biotech Monovalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Serum Biotech Recent Developments/Updates

3 Competitive Environment: Monovalent Antivenom by Manufacturer
    3.1 Global Monovalent Antivenom Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Monovalent Antivenom Revenue by Manufacturer (2018-2023)
    3.3 Global Monovalent Antivenom Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Monovalent Antivenom by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Monovalent Antivenom Manufacturer Market Share in 2022
        3.4.2 Top 6 Monovalent Antivenom Manufacturer Market Share in 2022
    3.5 Monovalent Antivenom Market: Overall Company Footprint Analysis
        3.5.1 Monovalent Antivenom Market: Region Footprint
        3.5.2 Monovalent Antivenom Market: Company Product Type Footprint
        3.5.3 Monovalent Antivenom Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Monovalent Antivenom Market Size by Region
        4.1.1 Global Monovalent Antivenom Sales Quantity by Region (2018-2029)
        4.1.2 Global Monovalent Antivenom Consumption Value by Region (2018-2029)
        4.1.3 Global Monovalent Antivenom Average Price by Region (2018-2029)
    4.2 North America Monovalent Antivenom Consumption Value (2018-2029)
    4.3 Europe Monovalent Antivenom Consumption Value (2018-2029)
    4.4 Asia-Pacific Monovalent Antivenom Consumption Value (2018-2029)
    4.5 South America Monovalent Antivenom Consumption Value (2018-2029)
    4.6 Middle East and Africa Monovalent Antivenom Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Monovalent Antivenom Sales Quantity by Type (2018-2029)
    5.2 Global Monovalent Antivenom Consumption Value by Type (2018-2029)
    5.3 Global Monovalent Antivenom Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Monovalent Antivenom Sales Quantity by Application (2018-2029)
    6.2 Global Monovalent Antivenom Consumption Value by Application (2018-2029)
    6.3 Global Monovalent Antivenom Average Price by Application (2018-2029)

7 North America
    7.1 North America Monovalent Antivenom Sales Quantity by Type (2018-2029)
    7.2 North America Monovalent Antivenom Sales Quantity by Application (2018-2029)
    7.3 North America Monovalent Antivenom Market Size by Country
        7.3.1 North America Monovalent Antivenom Sales Quantity by Country (2018-2029)
        7.3.2 North America Monovalent Antivenom Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Monovalent Antivenom Sales Quantity by Type (2018-2029)
    8.2 Europe Monovalent Antivenom Sales Quantity by Application (2018-2029)
    8.3 Europe Monovalent Antivenom Market Size by Country
        8.3.1 Europe Monovalent Antivenom Sales Quantity by Country (2018-2029)
        8.3.2 Europe Monovalent Antivenom Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Monovalent Antivenom Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Monovalent Antivenom Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Monovalent Antivenom Market Size by Region
        9.3.1 Asia-Pacific Monovalent Antivenom Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Monovalent Antivenom Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Monovalent Antivenom Sales Quantity by Type (2018-2029)
    10.2 South America Monovalent Antivenom Sales Quantity by Application (2018-2029)
    10.3 South America Monovalent Antivenom Market Size by Country
        10.3.1 South America Monovalent Antivenom Sales Quantity by Country (2018-2029)
        10.3.2 South America Monovalent Antivenom Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Monovalent Antivenom Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Monovalent Antivenom Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Monovalent Antivenom Market Size by Country
        11.3.1 Middle East & Africa Monovalent Antivenom Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Monovalent Antivenom Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Monovalent Antivenom Market Drivers
    12.2 Monovalent Antivenom Market Restraints
    12.3 Monovalent Antivenom Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Monovalent Antivenom and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Monovalent Antivenom
    13.3 Monovalent Antivenom Production Process
    13.4 Monovalent Antivenom Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Monovalent Antivenom Typical Distributors
    14.3 Monovalent Antivenom Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Monovalent Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Monovalent Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Monovalent Antivenom Product and Services
    Table 6. CSL Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. CSL Recent Developments/Updates
    Table 8. Merck Basic Information, Manufacturing Base and Competitors
    Table 9. Merck Major Business
    Table 10. Merck Monovalent Antivenom Product and Services
    Table 11. Merck Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Merck Recent Developments/Updates
    Table 13. BTG Basic Information, Manufacturing Base and Competitors
    Table 14. BTG Major Business
    Table 15. BTG Monovalent Antivenom Product and Services
    Table 16. BTG Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. BTG Recent Developments/Updates
    Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer Monovalent Antivenom Product and Services
    Table 21. Pfizer Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Pfizer Recent Developments/Updates
    Table 23. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 24. Haffkine Bio-Pharmaceutical Major Business
    Table 25. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
    Table 26. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Haffkine Bio-Pharmaceutical Recent Developments/Updates
    Table 28. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
    Table 29. Vins Bioproducts Major Business
    Table 30. Vins Bioproducts Monovalent Antivenom Product and Services
    Table 31. Vins Bioproducts Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Vins Bioproducts Recent Developments/Updates
    Table 33. Serum Biotech Basic Information, Manufacturing Base and Competitors
    Table 34. Serum Biotech Major Business
    Table 35. Serum Biotech Monovalent Antivenom Product and Services
    Table 36. Serum Biotech Monovalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Serum Biotech Recent Developments/Updates
    Table 38. Global Monovalent Antivenom Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 39. Global Monovalent Antivenom Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 40. Global Monovalent Antivenom Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 41. Market Position of Manufacturers in Monovalent Antivenom, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 42. Head Office and Monovalent Antivenom Production Site of Key Manufacturer
    Table 43. Monovalent Antivenom Market: Company Product Type Footprint
    Table 44. Monovalent Antivenom Market: Company Product Application Footprint
    Table 45. Monovalent Antivenom New Market Entrants and Barriers to Market Entry
    Table 46. Monovalent Antivenom Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Monovalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 48. Global Monovalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 49. Global Monovalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 50. Global Monovalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 51. Global Monovalent Antivenom Average Price by Region (2018-2023) & (US$/Unit)
    Table 52. Global Monovalent Antivenom Average Price by Region (2024-2029) & (US$/Unit)
    Table 53. Global Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 54. Global Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 55. Global Monovalent Antivenom Consumption Value by Type (2018-2023) & (USD Million)
    Table 56. Global Monovalent Antivenom Consumption Value by Type (2024-2029) & (USD Million)
    Table 57. Global Monovalent Antivenom Average Price by Type (2018-2023) & (US$/Unit)
    Table 58. Global Monovalent Antivenom Average Price by Type (2024-2029) & (US$/Unit)
    Table 59. Global Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 60. Global Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 61. Global Monovalent Antivenom Consumption Value by Application (2018-2023) & (USD Million)
    Table 62. Global Monovalent Antivenom Consumption Value by Application (2024-2029) & (USD Million)
    Table 63. Global Monovalent Antivenom Average Price by Application (2018-2023) & (US$/Unit)
    Table 64. Global Monovalent Antivenom Average Price by Application (2024-2029) & (US$/Unit)
    Table 65. North America Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 66. North America Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 67. North America Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 68. North America Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 69. North America Monovalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 70. North America Monovalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 71. North America Monovalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 72. North America Monovalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 73. Europe Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 74. Europe Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 75. Europe Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 76. Europe Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 77. Europe Monovalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 78. Europe Monovalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 79. Europe Monovalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Monovalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 82. Asia-Pacific Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 83. Asia-Pacific Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 84. Asia-Pacific Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 85. Asia-Pacific Monovalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 86. Asia-Pacific Monovalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 87. Asia-Pacific Monovalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 88. Asia-Pacific Monovalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 89. South America Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 90. South America Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 91. South America Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 92. South America Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 93. South America Monovalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 94. South America Monovalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 95. South America Monovalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 96. South America Monovalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Monovalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 98. Middle East & Africa Monovalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 99. Middle East & Africa Monovalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 100. Middle East & Africa Monovalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 101. Middle East & Africa Monovalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 102. Middle East & Africa Monovalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 103. Middle East & Africa Monovalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 104. Middle East & Africa Monovalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 105. Monovalent Antivenom Raw Material
    Table 106. Key Manufacturers of Monovalent Antivenom Raw Materials
    Table 107. Monovalent Antivenom Typical Distributors
    Table 108. Monovalent Antivenom Typical Customers
List of Figures
    Figure 1. Monovalent Antivenom Picture
    Figure 2. Global Monovalent Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Monovalent Antivenom Consumption Value Market Share by Type in 2022
    Figure 4. Coral Snakes Antivenom Examples
    Figure 5. Sea Snakes Antivenom Examples
    Figure 6. Brown Snake Antivenom Examples
    Figure 7. Others Examples
    Figure 8. Global Monovalent Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Monovalent Antivenom Consumption Value Market Share by Application in 2022
    Figure 10. Non-profit Institutions Examples
    Figure 11. Hospitals and Clinic Examples
    Figure 12. Global Monovalent Antivenom Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Monovalent Antivenom Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Monovalent Antivenom Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Monovalent Antivenom Average Price (2018-2029) & (US$/Unit)
    Figure 16. Global Monovalent Antivenom Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Monovalent Antivenom Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Monovalent Antivenom by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Monovalent Antivenom Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Monovalent Antivenom Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Monovalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Monovalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Monovalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Monovalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Monovalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Monovalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Monovalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Monovalent Antivenom Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Monovalent Antivenom Average Price by Type (2018-2029) & (US$/Unit)
    Figure 31. Global Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Monovalent Antivenom Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Monovalent Antivenom Average Price by Application (2018-2029) & (US$/Unit)
    Figure 34. North America Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Monovalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Monovalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Monovalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Monovalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Monovalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Monovalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Monovalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Monovalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Monovalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Monovalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Monovalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Monovalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Monovalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Monovalent Antivenom Market Drivers
    Figure 75. Monovalent Antivenom Market Restraints
    Figure 76. Monovalent Antivenom Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Monovalent Antivenom in 2022
    Figure 79. Manufacturing Process Analysis of Monovalent Antivenom
    Figure 80. Monovalent Antivenom Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech

Related Reports

Global Monovalent Antivenom Supply, Demand and Key Producers, 2023-2029

Global Monovalent Antivenom Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Monovalent Antivenom market size is expected to reach $ 484.8 million by 2029, rising at a market growth of 3.0% CAGR during the forecast period (2023-2029).

Global Monovalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Monovalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Monovalent Antivenom market size was valued at USD 395.1 million in 2023 and is forecast to a readjusted size of USD 484.8 million by 2030 with a CAGR of 3.0% during review period.

Global Monovalent Antivenom Supply, Demand and Key Producers, 2024-2030

Global Monovalent Antivenom Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Monovalent Antivenom market size is expected to reach $ 484.8 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>